A simple method for the production of recombinant proteins from mammalian cells

被引:14
作者
Wu, CH [1 ]
Balasubramanian, WR [1 ]
Ko, YP [1 ]
Hsu, G [1 ]
Chang, SE [1 ]
Prijovich, ZM [1 ]
Chen, KC [1 ]
Roffler, SR [1 ]
机构
[1] Acad Sinica, Inst Biomed Sci, Sect 2, Taipei 128, Taiwan
关键词
aminopeptidase N; ammonium sulphate; beta-glucuronidase; His tag; mammalian cell; purification;
D O I
10.1042/BA20030184
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of recombinant proteins in mammalian cells is useful for obtaining products with normal posttranslational modifications. We describe a simple and economical method for the production of milligram levels of proteins in murine fibroblasts. Retroviral or lipofectAMINE(TM) (Gibco Laboratories) transduction was employed to generate stable murine-fibroblast producer cells. Confluent cultures of stable fibroblast clones were maintained for up to 1 month in 0.5% serum. Culture medium was collected every 2-3 days and polyhistidine-tagged proteins were purified by ammonium sulphate precipitation and Ni2+-nitrilotriacetic acid affinity chromatography. Highly pure, active, glycosylated recombinant proteins, including human beta-glucuronidase, mouse beta-glucuronidase, aminopeptidase N (CD13) and a single-chain antibody-enzyme fusion protein, were obtained with yields of 3-6 mg/l of culture medium. Fc-tagged proteins were also produced and purified in a single step by Protein A affinity chromatography with yields of 6-12 mg/l. The techniques described here allow simple and economical production of recombinant mammalian proteins with post-translational modifications.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 26 条
[1]   Insect cells as hosts for the expression of recombinant glycoproteins [J].
Altmann, F ;
Staudacher, E ;
Wilson, IBH ;
März, L .
GLYCOCONJUGATE JOURNAL, 1999, 16 (02) :109-123
[2]   Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy [J].
Chen, BM ;
Cheng, TL ;
Tzou, SC ;
Roffler, SR .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (06) :850-858
[3]   Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs [J].
Cheng, TL ;
Chen, BM ;
Chan, LY ;
Wu, PY ;
Chern, JW ;
Roffler, SR .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 44 (06) :305-315
[4]   Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM [J].
Cheng, TL ;
Wu, PY ;
Wu, MF ;
Chern, JW ;
Roffler, SR .
BIOCONJUGATE CHEMISTRY, 1999, 10 (03) :520-528
[5]   Protein arrays: The current state-of-the-art [J].
Cutler, P .
PROTEOMICS, 2003, 3 (01) :3-18
[6]   BIOCHEMICAL-PROPERTIES OF RECOMBINANT HUMAN BETA-GLUCURONIDASE SYNTHESIZED IN BABY HAMSTER-KIDNEY CELLS [J].
GEHRMANN, MC ;
OPPER, M ;
SEDLACEK, HH ;
BOSSLET, K ;
CZECH, J .
BIOCHEMICAL JOURNAL, 1994, 301 :821-828
[7]   ISOLATION AND CHARACTERIZATION OF THE MAJOR FORM OF BETA-GLUCURONIDASE FROM HUMAN SEMINAL PLASMA [J].
GUPTA, GS ;
SINGH, GP .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 748 (03) :398-404
[8]   Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human β-glucuronidase for antibody-directed enzyme prodrug therapy [J].
Haisma, HJ ;
Sernee, MF ;
Hooijberg, E ;
Brakenhoff, RH ;
van den Meulen-Mulleman, IH ;
Pinedo, HM ;
Boven, E .
BLOOD, 1998, 92 (01) :184-190
[9]   Construction and characterization of a fusion protein of single-chain anti-carcinoma antibody 323/A3 and human β-glucuronidase [J].
Haisma, HJ ;
Brakenhoff, RH ;
Van der Meulen-Muileman, I ;
Pinedo, HM ;
Boven, E .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 45 (05) :266-272
[10]   Disease proteomics [J].
Hanash, S .
NATURE, 2003, 422 (6928) :226-232